Metadata Search Funding Data Link References Status API Help
Facet browsing currently unavailable
Page 3 of 6350 results
Sort by: relevance publication year

Corrigendum

JOURNAL ARTICLE published March 2020 in Multiple Sclerosis Journal

Letter To the Editor

JOURNAL ARTICLE published June 2007 in Multiple Sclerosis Journal

Authors: Anu Jacob | Sean J. Pittock

Neuromyelitis optica without typical opticospinal phenotype

JOURNAL ARTICLE published October 2010 in Multiple Sclerosis Journal

Authors: Douglas Sato | Kazuo Fujihara

Analysis of an interferon-γ gene dinucleotide-repeat polymorphism in Nordic multiple sclerosis patients

JOURNAL ARTICLE published June 2001 in Multiple Sclerosis Journal

Authors: Y Dai | T Masterman | W X Huang | M Sandberg-Wollheim | M Laaksonen | H F Harbo | A Oturai | L P Ryder | P Soelberg-Sørensen | A Svejgaard | J Hillert

Atorvastatin decreases high-sensitivity C-reactive protein in multiple sclerosis

JOURNAL ARTICLE published August 2008 in Multiple Sclerosis Journal

Authors: J Sellner | I Greeve | HP Mattle

A role for hypertrophic astrocytes and astrocyte precursors in a case of rapidly progressive multiple sclerosis

JOURNAL ARTICLE published August 2003 in Multiple Sclerosis Journal

Authors: Yvette Morcos | Sang Min Lee | Michael C Levin

Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study

JOURNAL ARTICLE published February 2017 in Multiple Sclerosis Journal

Authors: Ralf Gold | Douglas L Arnold | Amit Bar-Or | Michael Hutchinson | Ludwig Kappos | Eva Havrdova | David G MacManus | Tarek A Yousry | Carlo Pozzilli | Krysztof Selmaj | Marianne T Sweetser | Ray Zhang | Minhua Yang | James Potts | Mark Novas | David H Miller | Nuwan C Kurukulasuriya | Robert J Fox | Theodore J Phillips

Predicting ongoing adherence to disease modifying therapies in multiple sclerosis: utility of the health beliefs model

JOURNAL ARTICLE published November 2007 in Multiple Sclerosis Journal

Authors: A.P. Turner | D.R. Kivlahan | A.P. Sloan | J.K. Haselkorn

New insights into the burden and costs of multiple sclerosis in Europe: Results for Switzerland

JOURNAL ARTICLE published August 2017 in Multiple Sclerosis Journal

Authors: Pasquale Calabrese | Gisela Kobelt | Jenny Berg | Daniela Capsa | Jennifer Eriksson | The European Multiple Sclerosis Platform

New insights into the burden and costs of multiple sclerosis in Europe: Results for France

JOURNAL ARTICLE published August 2017 in Multiple Sclerosis Journal

Authors: Christine Lebrun-Frenay | Gisela Kobelt | Jenny Berg | Daniela Capsa | Mia Gannedahl | The European Multiple Sclerosis Platform

Disease progression in multiple sclerosis: combining physicians’ and patients’ perspectives?

JOURNAL ARTICLE published February 2011 in Multiple Sclerosis Journal

Authors: JJ Kragt | JM Nielsen | FAH van der Linden | CH Polman | BMJ Uitdehaag

Setting a research agenda for progressive multiple sclerosis: The International Collaborative on Progressive MS

JOURNAL ARTICLE published November 2012 in Multiple Sclerosis Journal

Authors: Robert J Fox | Alan Thompson | David Baker | Peer Baneke | Doug Brown | Paul Browne | Dhia Chandraratna | Olga Ciccarelli | Timothy Coetzee | Giancarlo Comi | Anthony Feinstein | Raj Kapoor | Karen Lee | Marco Salvetti | Kersten Sharrock | Ahmed Toosy | Paola Zaratin | Kim Zuidwijk

Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome

JOURNAL ARTICLE published July 2013 in Multiple Sclerosis Journal

Authors: Giancarlo Comi | Vittorio Martinelli | Mariaemma Rodegher | Lucia Moiola | Letizia Leocani | Ovidiu Bajenaru | Adriana Carra | Irina Elovaara | Franz Fazekas | Hans-Peter Hartung | Jan Hillert | John King | Samuel Komoly | Catherine Lubetzki | Xavier Montalban | Kjell-Morten Myhr | Paolo Preziosa | Mads Ravnborg | Peter Rieckmann | Maria A Rocca | Daniel Wynn | Carolyn Young | Massimo Filippi

Clinical impact of 20% worsening on Timed 25-foot Walk and 9-hole Peg Test in multiple sclerosis

JOURNAL ARTICLE published September 2006 in Multiple Sclerosis Journal

Authors: J J Kragt | F AH van der Linden | J M Nielsen | B MJ Uitdehaag | C H Polman

Impact of clinical outcomes and imaging measures on health-related quality of life in secondary progressive MS

JOURNAL ARTICLE published July 2022 in Multiple Sclerosis Journal

Authors: Marcus W Koch | Jop Mostert | Pavle Repovic | James D Bowen | Eva Strijbis | Bernard Uitdehaag | Gary Cutter

Radiologically isolated syndrome should be treated with disease-modifying therapy – Commentary

JOURNAL ARTICLE published December 2017 in Multiple Sclerosis Journal

Authors: Christine Lebrun

Fampridine-SR in multiple sclerosis: a randomized, double-blind, placebo-controlled, dose-ranging study

JOURNAL ARTICLE published April 2007 in Multiple Sclerosis Journal

Authors: A.D. Goodman | J.A. Cohen | A. Cross | T. Vollmer | M. Rizzo | R. Cohen | L. Marinucci | A.R. Blight

Serum MOG-IgG in children meeting multiple sclerosis diagnostic criteria

JOURNAL ARTICLE published October 2022 in Multiple Sclerosis Journal

Authors: Giulia Fadda | Patrick Waters | Mark Woodhall | Robert A Brown | Julia O’Mahony | Denise A Castro | Giulia Longoni | E Ann Yeh | Ruth Ann Marrie | Douglas L Arnold | Brenda Banwell | Amit Bar-Or

Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature

JOURNAL ARTICLE published August 2012 in Multiple Sclerosis Journal

Authors: S Jarius | F Paul | D Franciotta | J de Seze | C Münch | M Salvetti | K Ruprecht | M Liebetrau | KP Wandinger | G Akman-Demir | A Melms | W Kristoferitsch | B Wildemann

Area postrema syndrome: A short history of a pearl in demyelinating diseases

JOURNAL ARTICLE published March 2019 in Multiple Sclerosis Journal

Authors: Carlos R Camara-Lemarroy | Jodie M Burton